Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL648830 | 0.92 | C5AR1 (0.64) | C5AR1MAPTKDM4ETSHRKMT2A | |
| SCHEMBL652877 | 0.92 | C5AR1 (0.66) | C5AR1MAPTKDM4ETSHRKMT2A | |
| SCHEMBL4767016 | 0.90 | C5AR1 (0.75) | C5AR1MAPTKDM4ETSHRKMT2A | |
| SCHEMBL5135929 | 0.88 | C5AR1 (0.72) | C5AR1MAPTKDM4ETSHRKMT2A | |
| SCHEMBL649255 | 0.88 | C5AR1 (0.71) | C5AR1MAPTKDM4ETSHRKMT2A | |
| SCHEMBL650391 | 0.87 | C5AR1 (0.59) | C5AR1MAPTKDM4ETSHRKMT2A | |
| SCHEMBL5136954 | 0.87 | C5AR1 (0.60) | C5AR1MAPTKDM4ETSHRKMT2A | |
| SCHEMBL649645 | 0.87 | C5AR1 (0.70) | C5AR1MAPTKDM4ETSHRKMT2A | |
| SCHEMBL648372 | 0.87 | C5AR1 (0.70) | C5AR1MAPTKDM4ETSHRKMT2A | |
| SCHEMBL649446 | 0.86 | C5AR1 (0.72) | C5AR1MAPTKDM4ETSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116390691-A | Self-assembled amphiphilic peptide hydrogels | 歌尔4梅德股份有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-109154598-B | Methods, systems, and compositions for studying solvent accessibility and three-dimensional structure of biomolecules | 威斯康星校友研究基金会 | 2023-01-10 | — | — | CN | claimed |
| CN-114031718-A | Solvent type dispersion resin for high solid content coating and preparation method thereof | 上海金仕迈树脂有限公司 | 2022-02-11 | — | — | CN | claimed |
| CN-113181112-A | Neuroactive steroid solutions and methods of their use | 萨奇治疗股份有限公司 | 2021-07-30 | — | — | CN | claimed |
| CN-105377873-B | Elucidation of ion exchange chromatography input optimization | 豪夫迈·罗氏有限公司 | 2021-03-30 | — | — | CN | claimed |
| CN-112771378-B | Health care management method | 株式会社普欧威盖特 | 2024-07-05 | — | — | CN | disclosed |
| CN-115484957-B | Formulations for treating ocular conditions | 兰泰克生物技术公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-118234867-A | Compositions and methods for producing cyclic polyribonucleotides | 旗舰创业创新六公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-117923676-A | Methods and compositions for reducing azole and AOX corrosion inhibitors | BL 科技公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-115667149-B | Cerium oxide nanoparticle, dispersion containing cerium oxide nanoparticle, oxidizing agent, antiviral agent, and antibacterial agent | 东丽株式会社 | 2024-03-08 | — | — | CN | disclosed |
| CN-117587645-A | Reaction liquid for pigment printing and dyeing, ink set and recording method | 精工爱普生株式会社 | 2024-02-23 | — | — | CN | disclosed |
| CN-117582496-A | Antibody compositions | 美勒斯公司 | 2024-02-23 | — | — | CN | disclosed |
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007145824-A2 | SELF-FOAMING CEMENT FOR VOID FILLING AND/OR DELIVERY SYSTEMS | KYPHON SARL (CH) | 2007-12-21 | — | — | WO | disclosed |
| US-20070283849-A1 | Self-foaming cement for void filling and/or delivery systems | SANATIS GMBH (DE) | 2007-12-13 | — | — | US | disclosed |
| US-7186734-B2 | Aryl imidazoles and related compounds as C5a receptor modulators | NEUROGEN CORPORATION (US) | 2007-03-06 | — | — | US | disclosed |
| US-7186734-B2 | Aryl imidazoles and related compounds as C5a receptor modulators | NEUROGEN CORPORATION (US) | 2007-03-06 | — | — | US | disclosed |
| US-7186734-B2 | Aryl imidazoles and related compounds as C5a receptor modulators | NEUROGEN CORPORATION (US) | 2007-03-06 | — | — | US | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |